SocGen Quants Skeptical on Stocks Amid ‘Wobbly’ Cyclicals Rally
(Bloomberg) -- U.S. stocks may be well off their mid-March lows, but Societe Generale SA's quantitative strategists are wary of the rally.
“From a market technical perspective, the cyclical recovery has been very volatile, wobbly, up one week, down the next, indicating the fragility of the market recovery,” Solomon Tadesse, head of North American equity quant research, said in an email May 31. “If this is a true economic recovery and if the March market plunge is the market bottom, we should see a clear and strong rebound in cyclicals.”
Cyclical stocks, those that benefit most when the economy is running hot, have shown some signs of resurgence. On Tuesday and Wednesday last week, the Russell 2000 Index outperformed the tech-heavy Nasdaq-100 Index by more than 2.5 percentage points only to lag behind by about 2 percentage points in each of the following two sessions. The Russell 1000 Value Index behaved similarly relative to its Growth counterpart.
“The worst may not be over for the market,” Tadesse and colleagues including Andrew Lapthorne wrote in a separate note May 28 that studied the past 100 years of market downturns and recoveries. While optimism about economic recovery might be spurring gains in cyclicals, the uncertainty about how the pandemic will end, and the timeline of potential vaccines, will limit their advance, they said.
SocGen's warning comes as Goldman Sachs Group Inc. on May 29 pared its forecast for further declines, citing the strength of stock gains and support from fiscal stimulus and monetary policy. Strategists led by David Kostin moved their downside S&P 500 forecast to 2,750, from a previous 2,400, compared with the May 29 close of 3,044.
Still, Goldman sees a number of reasons to be cautious on U.S. stocks, including lack of buybacks and narrow participation in the recent gains. Even JPMorgan Chase & Co., which made an early call that the worst was behind markets, tamped down its optimism on equities last week.
The situation further out in the future is promising, Tadesse said.
“In the medium term, as all clears up and economic recovery holds, I expect a significant cyclical rally, given also the depressed valuations,” he said.
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.